Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab and Vasoconstriction
- Status
- COMPLETED
- Phase
- NA
Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Pilot Study of Bevacizumab for Neoplastic Meningitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
- Status
- TERMINATED
- Phase
- PHASE2
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TC Avastin. ICORG 08-10, V6
- Status
- COMPLETED
- Phase
- NA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
- Status
- COMPLETED
- Phase
- PHASE3
Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab to Prevent Malignant Ascites
- Status
- WITHDRAWN
- Phase
- PHASE2
Bevacizumab for Central Retinal Vein Occlusion Study
- Status
- COMPLETED
- Phase
- PHASE3